To arrange an interview, please contact the NHLBI Communications Office at 301-496-4236 or email@example.com.
Donna DiMichele, M.D., is the deputy director of the Division of Blood Diseases and Resources at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). She also maintains an appointment in the Department of Pediatrics at the Weill Cornell Medical College in New York City.
In her position at the NHLBI, Dr. DiMichele has been involved in an NHLBI Pediatric Research Interest Group that has begun to explore the potential research areas in hematology, cardiology, and pulmonology of interest to both the NHLBI and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Within this framework, she is particularly interested in exploring the potential for NIH-wide collaboration to generate Small Business Innovation Research/Small Business Technology Transfer opportunities in the development of devices, pediatric-specific metrics, and microfluidic assays required to further neonatal and pediatric research in lung, heart, and blood diseases. Dr. DiMichele continues to seek opportunities where the NHLBI can facilitate multicenter clinical trials, which builds upon her interests in pediatric and rare blood diseases research as well as clinical trials in blood diseases.
Dr. DiMichele specializes in hematology and rare bleeding disorders, and has conducted extensive research with both government and private industry funding. In addition, she organized clinical trials, directed several fellowship programs, and was a pioneer in raising awareness of a serious complication of hemophilia treatment. Her vast clinical expertise allows her to identify areas in hematology that could benefit from translational research initiatives, and her expertise in medical ethics is a great benefit as the NHLBI develops and funds clinical studies and treatments.
Dr. DiMichele came to the NHLBI in January 2010 from Weill Cornell Medical College, where she was a professor of pediatrics and public health as well as an ombudsman. She also directed the Regional Comprehensive Hemophilia Diagnostic and Treatment Center for over 10 years and served as an attending physician at several of New York City's top hospitals.
Dr. DiMichele received her medical education at McGill University in Montreal, Canada. Her research interests and publications have focused on inhibitor epidemiology and immune tolerance; severe hemophilia in females; rare bleeding disorders and the ethics of high risk research in children with hemophilia.
She has previously served as co-PI of the International Immune Tolerance Study; co-chair of the UDC Working Party on Rare Bleeding and Clotting Disorders (charged with the responsibility of developing a national database on rare plasma protein disorders); and the PI of both the U.S. and International Severe Hemophilia in Females studies.
Areas of expertise: hematology and rare blood diseases research